Keyword | CPC | PCC | Volume | Score | Length of keyword |
---|---|---|---|---|---|
keynote 564 clinical trial | 0.73 | 0.7 | 159 | 93 | 26 |
keynote | 1.98 | 0.4 | 8071 | 86 | 7 |
564 | 0.14 | 0.3 | 7864 | 4 | 3 |
clinical | 0.5 | 0.5 | 9073 | 66 | 8 |
trial | 0.61 | 0.5 | 2092 | 81 | 5 |
Keyword | CPC | PCC | Volume | Score |
---|---|---|---|---|
keynote 564 clinical trial | 1.83 | 0.2 | 9725 | 57 |
keynote 522 clinical trial | 0.5 | 0.5 | 8126 | 32 |
keynote 966 clinical trial | 1.63 | 0.2 | 7898 | 86 |
keynote 775 clinical trial | 1.97 | 0.3 | 1014 | 11 |
keynote 671 clinical trial | 1.73 | 0.6 | 40 | 79 |
keynote 811 clinical trial | 1.9 | 0.7 | 564 | 35 |
keynote 522 breast cancer trial | 0.75 | 0.3 | 3766 | 84 |
keynote 564 study design | 0.62 | 0.4 | 5060 | 76 |
keynote 522 trial protocol | 1.92 | 0.3 | 4494 | 34 |
keynote 522 trial regimen | 0.6 | 0.5 | 868 | 71 |
keynote-564 | 1.49 | 0.7 | 7533 | 57 |
keynote-177 trial | 1.85 | 0.5 | 8063 | 62 |
clinical trial government nct05526521 | 0.66 | 0.4 | 1201 | 87 |
keynote trial breast cancer | 1.93 | 0.8 | 4852 | 24 |
nct05086276 clinical trial outcome | 0.8 | 1 | 3446 | 4 |
keynote 564 inclusion criteria | 1.35 | 0.5 | 2712 | 94 |
keynote-028 trial | 1.96 | 0.4 | 3359 | 84 |
keynote 522 trial design | 1.8 | 0.5 | 993 | 28 |
keynote trial cervical cancer | 1.54 | 0.7 | 2876 | 86 |
keynote-671 nct03425643 | 1.58 | 0.7 | 5748 | 76 |
clinical trials notes pdf | 0.73 | 0.2 | 2280 | 56 |
clinicaltrials.gov nct04491695 | 0.16 | 1 | 5198 | 81 |
keynote-158 nct02628067 | 0.53 | 0.2 | 6949 | 40 |
clinicaltrials.gov nct00159679 | 0.42 | 0.6 | 9651 | 81 |
clinicaltrials.gov nct03225339 | 1.37 | 0.8 | 6555 | 87 |